| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NovoCure Ltd | Executive Chairman, Director | Ordinary Shares | 551K | $6.97M | $12.65 | Aug 2, 2022 | Direct |
| Elanco Animal Health Inc | Director | Common Stock | 76.3K | $1.3M | $16.98 | May 21, 2024 | Direct |
| PROKIDNEY CORP. | Director | Director stock option (right to buy) | 62.6K | May 30, 2024 | Direct | ||
| Minerva Neurosciences, Inc. | Director | Stock Option (right to buy) | 2.5K | Jun 10, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PROK | PROKIDNEY CORP. | May 30, 2024 | 1 | $0 | 4 | Jun 3, 2024 | Director |
| ELAN | Elanco Animal Health Inc | May 21, 2024 | 1 | $255K | 4 | May 23, 2024 | Director |
| ELAN | Elanco Animal Health Inc | Mar 8, 2024 | 1 | $245K | 4 | Mar 12, 2024 | Director |
| ELAN | Elanco Animal Health Inc | Nov 30, 2023 | 1 | $0 | 4 | Dec 4, 2023 | Director |
| PROK | PROKIDNEY CORP. | Jun 29, 2023 | 1 | $0 | 4 | Jul 3, 2023 | Director |
| ELAN | Elanco Animal Health Inc | Nov 30, 2022 | 1 | $0 | 4 | Dec 2, 2022 | Director |
| NVCR | NovoCure Ltd | Aug 2, 2022 | 1 | -$58.3K | 4 | Aug 3, 2022 | Executive Chairman, Director |
| PROK | PROKIDNEY CORP. | Jul 11, 2022 | 2 | $0 | 4 | Jul 13, 2022 | Director |
| PROK | PROKIDNEY CORP. | Jul 11, 2022 | 0 | $0 | 3 | Jul 13, 2022 | Director |
| NERV | Minerva Neurosciences, Inc. | Jun 10, 2022 | 1 | $0 | 4 | Jun 28, 2022 | Director |
| NVCR | NovoCure Ltd | Mar 8, 2022 | 1 | -$167K | 4 | Mar 9, 2022 | Executive Chairman, Director |
| NVCR | NovoCure Ltd | Mar 3, 2022 | 1 | $1.18M | 4 | Mar 7, 2022 | Executive Chairman, Director |
| ELAN | Elanco Animal Health Inc | Nov 30, 2021 | 1 | $0 | 4 | Dec 2, 2021 | Director |
| NVCR | NovoCure Ltd | Aug 2, 2021 | 1 | -$149K | 4 | Aug 4, 2021 | Executive Chairman, Director |
| NERV | Minerva Neurosciences, Inc. | Jun 11, 2021 | 1 | $0 | 4 | Jun 15, 2021 | Director |